LublinFDReingoldSCCohenJA. Defining the clinical course of multiple sclerosis: The 2013 revisions. Neurology2014; 83: 278–286.
2.
SombekkeMHWattjesMPBalkLJ. Spinal cord lesions in patients with clinically isolated syndrome: A powerful tool in diagnosis and prognosis. Neurology2013; 80: 69–75.
3.
PatruccoLRojasJICristianoE. Assessing the value of spinal cord lesions in predicting development of multiple sclerosis in patients with clinically isolated syndromes. J Neurol2012; 259: 1317–1320.
4.
RíoJNosCTintoréM. Defining the response to interferon-beta in relapsing–remitting multiple sclerosis patients. Ann Neurol2006; 59: 344–352.
5.
SormaniMPRioJTintorèM. Scoring treatment response in patients with relapsing multiple sclerosis. Mult Scler J2013; 19: 605–612.
6.
SormaniMSignoriAStromilloM. Refining response to treatment as defined by the Modified Rio Score. Mult Scler J2013; 19: 1246–1247.
7.
TeunissenCEKhalilM.Neurofilaments as biomarkers in multiple sclerosis. Mult Scler J2012; 18: 552–556.